The FDA has issued warnings to Albertsons, Kroger, Target, and Walmart for failing to properly remove recalled infant formula linked to botulism from their shelves. This corporate negligence has endangered our most vulnerable citizens and represents a shocking failure of basic consumer protection responsibilities.
A Johns Hopkins study analyzing FDA internal documents reveals the agency consistently based mifepristone regulatory decisions on scientific evidence from 2011-2023, with one notable political interference during the Trump administration. This chilling episode demonstrates how fragile evidence-based governance becomes when political agendas override medical expertise, threatening both reproductive freedom and institutional integrity.
FDA Commissioner Marty Makary reportedly delayed releasing a study on abortion pill safety until after the midterm elections, an act of political manipulation that subverts scientific integrity and betrays public trust in our nation's institutions.
President Donald Trump has nominated Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration, a move that would place a political loyalist and critic of established science in charge of a critical public health agency. This nomination represents a direct assault on scientific integrity and the very foundations of public health policy, prioritizing political agendas and ideological crusades over the lives and well-being of the American people.
President Trump has nominated Dr. Heidi Overton, a White House health policy aide and supporter of controversial vaccine schedule changes, to lead the FDA. This nomination, prioritizing political alignment over established scientific expertise at a time of severe agency attrition and a food safety crisis, poses a direct threat to public trust and the foundational, non-partisan mission of a critical health institution.
